510(k) K212284
K212284 is an FDA 510(k) premarket notification submitted by Suzhou Leapmed Healthcare Corporation for the device "Disposable Automatic Core Biopsy Instrument". The FDA issued a decision of Substantially Equivalent on November 10, 2021. The device falls under product code KNW (Instrument, Biopsy), a Class II device regulated under 21 CFR 876.1075. Suzhou Leapmed Healthcare Corporation has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 10, 2021
- Date Received
- July 21, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Instrument, Biopsy
- Device Class
- Class II
- Regulation Number
- 876.1075
- Review Panel
- SU
- Submission Type